Novavax CEO on Sanofi deal: 'This is a new chapter in the history of our company'

  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 46 sec. here
  • 6 min. at publisher
  • 📊 Quality Score:
  • News: 36%
  • Publisher: 63%

John Jacobs News

Sanofi,Biotech Company,Novavax

Novavax stock popped Friday on news of a licensing deal and minority stake from Big Pharma player Sanofi.

The deal gave Novavax a much-needed cash boost, helping it reverse more than a year of declining value.

When asked if Sanofi had previously approached Novavax for partnership, CEO Jacobs said he couldn't comment. Novavax beat on earnings per share, at $1.08 versus consensus estimates of $1.05, but it missed on revenues, reporting $98.3 million compared to Wall Street expectations of more than $101 million.is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, care services, digital health, PBMs, and health policy and politics.

Warren Buffett teased a potential Canada bet, predicted Berkshire would surpass $200 billion in cash this quarter, and shrugged off dollar worries.TD Bank stock looks like a great bargain after its latest plunge over the ongoing U.S. probe. The post TD Bank Stock Falls 6% on Money-Laundering Investigation: Deal or Danger? appeared first on The Motley Fool Canada.BCE Inc stock has a high yield but persistently negative earnings growth.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 47. in SG
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Singapore Singapore Latest News, Singapore Singapore Headlines